FIELD: molecular biology, microbiology, vaccines. SUBSTANCE: invention relates to vaccine used for struggle against infections caused by B. bronchiseptica in susceptible animals (dogs and pigs). Vaccine has proteins or polypeptides that are typical for B. bronchiseptica fimbria protein or recombinant polynucleotides. Vaccine can be used by oral, intranasal or intramuscular route. EFFECT: vaccine against infections. 7 cl, 1 tbl, 7 dwg, 4 ex
Authors
Dates
1999-04-27—Published
1993-07-28—Filed